This activity is intended for Basic Science Researchers, Translational Researchers, Clinical Researchers, Clinical Nurse Specialists, Physio / Physical Therapists, and Occupational Therapists.

Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.

All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available below. All relevant financial relationships have been mitigated in advance of this program.

Faculty Disclosures

Angelo Antonini
Speaker
Nothing to Disclose

Filip Bergquist
Speaker
Grant: Neuroförbundet, R&D Västra Götaland

K. Ray Chaudhuri
Speaker
Consultant: AbbVie, UCB, GKC, Bial, Cynapsus, Lobsor, Stada, Medtronic, Zambon, Profile, Sunovion, Roche, Theravance, Scion, Britannia, Acadia, 4D
Speaker: AbbVie, Britannia, UCB, Mundipharma, Zambon, Novartis,Boehringer Ingelheim
Grant: Britannia Pharmaceuticals, AbbVie, UCB, GKC, Bial, EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), MRC, Wellcome Trust

David Devos
Planner, Speaker
Consultant: Abbvie, Alterity, Orkyn, Air Liquide, Apopharma, Lundbeck, Everpharma and Boston Scientific, Cure Parkinson Trust
Grant: PHRC grants, ANR, Coen, Horizon 2020
Equity Stake: InBrain Pharma

Cristian Falup-Pecurariu
Speaker
Nothing to Disclose

Tove Henriksen
Speaker
Researcher: AbbVie
Speaker: Britannia, EVER Pharma, AbbVie, Neuroderm

Per Odin
Planner, Speaker
Nothing to Disclose

Anna Sauerbier
Planner, Speaker
Nothing to Disclose

Fabrizio Stocchi
Speaker
Consultant: Chiesi Ltd., GlaxoSmithKline Plc., Impax Laboratories Inc., Lundbeck Ltd, Teva UK Limited, UCB Pharma Ltd, Merck & Co. Inc, Zambon Pharma, Novartis AG

Lars Timmermann
Speaker
Grant: Hoffnungsbaum e.V., Medtronic Inc., TEVA, Bayer, zur Rose Pharma, UCB
Speaker: TEVA, Lundbeck, Bracco, Gianni PR, Medas Pharma, UCB Schwarz Pharma, Desitin Pharma, Boehringer Ingelheim, GlaxoSmithKline, Eumecom, Orion Pharma, Medtronic, Boston Scientific, Cephalon, Abott, GE Medical
Consultant: Medtronic Inc., Boston Scientific, Bayer Healthcare, UCB Schwarz Pharma, AMN, GlaxoSmithKline, Abbott, Archimedes

Tamine Capato
Reviewer
Nothing to Disclose

Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:
The International Parkinson and Movement Disorder Society designates this activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
   
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
   
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
   
4. Adobe Flash Player 12.0 (or higher).
   
5. Adobe Reader to print certificate.

MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.